Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stangel

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Deutsche Medizinische Wochenschrift (1946)|March 22, 2012
[Immunoglobulins in PID, SID and neurological autoimmune disease]M Borte, U Baumann, D Pittrow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 5, 2014
Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patientsR Hoepner, J Ahlbrecht, S Faissner, et al.
Der Nervenarzt|June 10, 2011
[Risk stratification of progressive multifocal leukoencephalopathy under natalizumab: recommendations for JC virus serology]C Warnke, O Adams, H P Hartung, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 9, 2021
A rare case of neuro- and otosyphilis in secondary syphilisS Traidl, Y Angela, A Stender, et al.
Neurology|November 30, 2006
Blockade of chemokine signaling in patients with multiple sclerosisF Zipp, H P Hartung, J Hillert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2012
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapyA Harrer, H Tumani, S Niendorf, et al.
Der Nervenarzt|August 14, 2015
[Current aspects of therapy conversion for multiple sclerosis]P Kolber, F Luessi, S G Meuth, et al.
Der Nervenarzt|March 2, 2016
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]L Klotz, A Berthele, W Brück, et al.
Neurological Research and Practice|December 16, 2020
S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version)H Tumani, H F Petereit, A Gerritzen, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Deutsche Medizinische Wochenschrift (1946)|March 22, 2012
[Immunoglobulins in PID, SID and neurological autoimmune disease]M Borte, U Baumann, D Pittrow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 5, 2014
Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patientsR Hoepner, J Ahlbrecht, S Faissner, et al.
Der Nervenarzt|June 10, 2011
[Risk stratification of progressive multifocal leukoencephalopathy under natalizumab: recommendations for JC virus serology]C Warnke, O Adams, H P Hartung, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 9, 2021
A rare case of neuro- and otosyphilis in secondary syphilisS Traidl, Y Angela, A Stender, et al.
Neurology|November 30, 2006
Blockade of chemokine signaling in patients with multiple sclerosisF Zipp, H P Hartung, J Hillert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2012
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapyA Harrer, H Tumani, S Niendorf, et al.
Der Nervenarzt|August 14, 2015
[Current aspects of therapy conversion for multiple sclerosis]P Kolber, F Luessi, S G Meuth, et al.
Der Nervenarzt|March 2, 2016
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]L Klotz, A Berthele, W Brück, et al.
Neurological Research and Practice|December 16, 2020
S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version)H Tumani, H F Petereit, A Gerritzen, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 7